Literature DB >> 8987762

Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy.

M E Helgren1, K D Cliffer, K Torrento, C Cavnor, R Curtis, P S DiStefano, S J Wiegand, R M Lindsay.   

Abstract

Chronic treatment of adult rats for 2-3 weeks with high doses of pyridoxine (vitamin B6) produced a profound proprioceptive loss, similar to that found in humans overdosed with this vitamin or treated with the chemotherapeutic agent cisplatin. Pyridoxine toxicity was manifest as deficits in simple and precise locomotion and sensory nerve function and as degeneration of large-diameter/large-fiber spinal sensory neurons. As assessed quantitatively in a beam-walking task and by EMG recording of H waves evoked by peripheral nerve stimulation, coadministration of the neurotrophic factor neurotrophin-3 (NT-3; 5-20 mg . kg-1 . d-1, s.c.) during chronic pyridoxine treatment largely attenuated the behavioral and electrophysiological sequelae associated with pyridoxine toxicity. Furthermore, NT-3 administration prevented degeneration of sensory fibers in the dorsal column of the spinal cord. These data are consistent with the evidence that NT-3 is a target-derived neurotrophic factor for muscle sensory afferents and suggest that pharmacological doses of NT-3 may be beneficial in the treatment of large-fiber sensory neuropathies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8987762      PMCID: PMC6793704     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  34 in total

1.  Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family.

Authors:  A Hohn; J Leibrock; K Bailey; Y A Barde
Journal:  Nature       Date:  1990-03-22       Impact factor: 49.962

2.  Alteration of neuronal cytoskeletal organization in dorsal root ganglia associated with pyridoxine neurotoxicity.

Authors:  V J Montpetit; D F Clapin; L Tryphonas; S Dancea
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Taxol produces a predominantly sensory neuropathy.

Authors:  R B Lipton; S C Apfel; J P Dutcher; R Rosenberg; J Kaplan; A Berger; A I Einzig; P Wiernik; H H Schaumburg
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

4.  Sympathetic neurons in neonatal rats require endogenous neurotrophin-3 for survival.

Authors:  X F Zhou; R Rush
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

5.  Pyridoxine megavitaminosis: an analysis of the early changes induced with massive doses of vitamin B6 in rat primary sensory neurons.

Authors:  G Krinke; D C Naylor; V Skorpil
Journal:  J Neuropathol Exp Neurol       Date:  1985-03       Impact factor: 3.685

6.  Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function.

Authors:  A Krarup-Hansen; K Fugleholm; S Helweg-Larsen; E N Hauge; H Schmalbruch; W Trojaborg; C Krarup
Journal:  Brain       Date:  1993-10       Impact factor: 13.501

7.  Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements.

Authors:  R Klein; I Silos-Santiago; R J Smeyne; S A Lira; R Brambilla; S Bryant; L Zhang; W D Snider; M Barbacid
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

8.  Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome.

Authors:  H Schaumburg; J Kaplan; A Windebank; N Vick; S Rasmus; D Pleasure; M J Brown
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

9.  Pyridoxine neuropathy: correlation of functional tests and neuropathology in beagle dogs treated with large doses of vitamin B6.

Authors:  U Schaeppi; G Krinke
Journal:  Agents Actions       Date:  1982-10

10.  Sensory ganglia require neurotrophin-3 early in development.

Authors:  F Gaese; R Kolbeck; Y A Barde
Journal:  Development       Date:  1994-06       Impact factor: 6.868

View more
  16 in total

1.  Neurotrophin modulation of the monosynaptic reflex after peripheral nerve transection.

Authors:  L M Mendell; R D Johnson; J B Munson
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

Review 2.  Peripheral nerve regeneration and neurotrophic factors.

Authors:  G Terenghi
Journal:  J Anat       Date:  1999-01       Impact factor: 2.610

Review 3.  Regulation of neurotrophin signaling in aging sensory and motoneurons: dissipation of target support?

Authors:  B Ulfhake; E Bergman; E Edstrom; B T Fundin; H Johnson; S Kullberg; Y Ming
Journal:  Mol Neurobiol       Date:  2000-06       Impact factor: 5.590

Review 4.  Neurotrophins and synaptic plasticity in the mammalian spinal cord.

Authors:  L M Mendell; J B Munson; V L Arvanian
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

5.  Pyridoxine treatment alters embryonic motility in chicks: Implications for the role of proprioception.

Authors:  Andrew A Sharp; Anne Bekoff
Journal:  Dev Psychobiol       Date:  2015-02-02       Impact factor: 3.038

6.  [Thiamine, pyridoxine and cobalamine. From myths to pharmacology and clinical practice].

Authors:  S Jesse; A C Ludolph
Journal:  Nervenarzt       Date:  2012-04       Impact factor: 1.214

7.  Teratogenic effects of pyridoxine on the spinal cord and dorsal root ganglia of embryonic chickens.

Authors:  A A Sharp; Y Fedorovich
Journal:  Neuroscience       Date:  2015-01-13       Impact factor: 3.590

8.  Nerve growth factor- and neurotrophin-3-induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord.

Authors:  M Malcangio; N E Garrett; S Cruwys; D R Tomlinson
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

Review 9.  Gene therapy for the treatment of diabetic neuropathy.

Authors:  Marina Mata; Munmun Chattopadhyay; David J Fink
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

10.  Proprioceptive neuropathy affects normalization of the H-reflex by exercise after spinal cord injury.

Authors:  Karen Ollivier-Lanvin; Benjamin E Keeler; Rachel Siegfried; John D Houlé; Michel A Lemay
Journal:  Exp Neurol       Date:  2009-11-11       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.